Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Investigation of the Biomarker Copeptin in Patients With Acute Myocardial Infarction (CHOPIN)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Brahms AG
ClinicalTrials.gov Identifier:
NCT00952744
First received: July 20, 2009
Last updated: January 16, 2012
Last verified: January 2012